Rosetta Genomics Ltd. provides therapeutic, diagnostic product development and medical research services. The company develops and commercializes new diagnostic tests based on various genomics markers, including DNA, microRNA and protein biomarkers and using various technologies, including, qPCR, microarrays, next generation sequencing and fluorescence in situ hybridization. It offers proprietary microRNA technologies, such as Rosetta Cancer Origin, mi-KIDNEY, and RosettaGX Reveal Test. The company was founded by Isaac Bentwich on March 9, 2000 and is headquartered in Rehovot, Israel.
Company profile
Ticker
ROSGQ
Exchange
CEO
Kenneth A. Berlin
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
SEC CIK
Corporate docs
ROSGQ stock data
Latest filings (excl ownership)
25-NSE
Exchange delisting
19 Jul 18
6-K
Current report (foreign)
18 May 18
NT 20-F
Notice of late annual filing (foreign)
1 May 18
6-K
Current report (foreign)
27 Apr 18
6-K
Rosetta Genomics Announces Shareholder Approval of Merger with Genoptix
26 Apr 18
6-K
Current report (foreign)
19 Apr 18
6-K
Amendment No. 2 to Agreement and Plan of Merger
19 Apr 18
6-K
Rosetta Genomics Urges Shareholders to Vote FOR the Proposed Merger with Genoptix
17 Apr 18
6-K
If shareholders do not approve the merger, outstanding ordinary shares likely will cease to have any value
10 Apr 18
6-K
Current report (foreign)
10 Apr 18
Latest ownership filings
4
Change in insider ownership
22 Apr 19
SC 13G/A
Rosetta Genomics Ltd.
4 Jan 19
SC 13G/A
Rosetta Genomics Ltd.
7 Jun 18
4
Change in insider ownership
27 Apr 18
4
Change in insider ownership
19 Mar 18
4
Change in insider ownership
16 Mar 18
3
Initial statement of insider ownership
14 Mar 18
4
Change in insider ownership
14 Mar 18
SC 13G
Rosetta Genomics Ltd.
12 Mar 18
SC 13G/A
Rosetta Genomics Ltd.
12 Feb 18
Institutional ownership, Q1 2021
0.1% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 1 |
Opened positions | 0 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 1.00 k |
Total shares | 8.65 k |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Highlander Capital Management | 8.65 k | $1.00 k |